-
What precautions can be taken to avoid norovirus during winter?
To avoid norovirus during winter, practice good hygiene by washing your hands frequently with soap and water, especially after using the restroom and before eating. Avoid close contact with infected individuals and disinfect surfaces regularly, particularly in shared spaces. If you experience symptoms of norovirus, stay home to prevent spreading the virus.
-
How can air quality be improved in homes during winter months?
Improving indoor air quality during winter can be achieved by regularly ventilating your home, using air purifiers, and keeping humidity levels between 30-50%. Avoid using tobacco indoors and limit the use of candles or incense. Regularly clean and replace HVAC filters to ensure optimal air circulation and reduce allergens.
-
What are the best practices for managing allergies in cold weather?
To manage allergies in cold weather, keep windows closed to prevent outdoor allergens from entering your home. Use high-efficiency particulate air (HEPA) filters in your home and consider using a dehumidifier to reduce mold growth. Regularly wash bedding and vacuum carpets to minimize dust mites and other allergens.
-
How does winter affect the spread of norovirus?
Winter can increase the spread of norovirus due to people spending more time indoors in close quarters, facilitating transmission. Additionally, colder temperatures can weaken the immune system, making individuals more susceptible to infections. It's essential to remain vigilant about hygiene practices during this season.
-
What is the link between air pollution and allergies?
Recent studies have shown that high levels of air pollution can increase the risk of developing allergies, particularly in children. Pollutants may trigger an overreaction of the immune system, leading to allergic responses. Improving air quality both indoors and outdoors is vital for reducing allergy risks.
-
What is the latest on norovirus vaccine trials?
The world's first norovirus vaccine, developed by Moderna, is currently in final testing phases. This mRNA vaccine aims to reduce hospitalizations and healthcare costs associated with norovirus, which is highly contagious and causes significant illness, especially among vulnerable populations. The trials involve 25,000 participants globally.